Cargando…
An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English NHS perspective
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Other. Main funding source(s): This cost-effectiveness study was funded by Medtronic BACKGROUND: The UK National Institute of Care Excellence (NICE) recommend the use of pulmonary vein isolation (PVI) to treat paroxysmal atrial fibrillation (PAF) in...
Autores principales: | Andrade, J, Moss, J, Todd, D, Kuniss, M, Wazni, O, Chierchia, G B, Mealing, S, Sale, A, Ismyrloglou, E, Souter, M, Bromilow, T, Lane, E, Lewis, D, Paisey, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207462/ http://dx.doi.org/10.1093/europace/euad122.688 |
Ejemplares similares
-
Cryoballoon ablation for atrial fibrillation in octogenarians: a propensity-score matching comparison with a cohort of younger patients
por: Cecchini, F, et al.
Publicado: (2023) -
Pulsed field versus cryoballoon ablation of atrial fibrillation: A comparison of efficacy and safety in a 400 patient cohort
por: Urbanek, L, et al.
Publicado: (2023) -
Efficacy and safety outcomes of early versus late cryoballoon ablation of atrial fibrillation - 24-months-results from the Cryo Global Registry
por: Lawin, D, et al.
Publicado: (2023) -
A novel saline-based occlusion tool allows for dye-less cryoballoon-based pulmonary vein isolation and fluoroscopy reduction
por: Rottner, L, et al.
Publicado: (2023) -
The outcomes of cryoballoon, high-power short-duration, and conventional radiofrequency atrial fibrillation catheter ablation: a propensity score weighted study
por: Park, H, et al.
Publicado: (2023)